166 results on '"Mok, T.S.K."'
Search Results
152. 730P - A Phase Ii Study on Combination of Axitinib and Transarterial Chemoembolization (Tace) for Treatment of Inoperable Hepatocellular Carcinoma (Hcc)
153. 205P - Efficacy Analysis of Gefitinib +/- Ficlatuzumab in Serum Proteomic Based Subgroups of Patients with Previously Untreated Lung Adenocarcinoma
154. An analysis of the antiemetic protection of metoclopramide plus dexamethasone in Chinese patients receiving moderately high emetogenic chemotherapy
155. Optimal Control of a Cancer Chemotherapy Problem with Different Toxic Elimination Processes.
156. Upper GI and Oncology 01
157. Hemorrhagic Pyelitis, Ureteritis, and Cystitis Secondary to Cyclophosphamide: Case Report and Review of the Literature
158. A phase II study of gemcitabine plus oral etoposide (GOE) in treatment of advanced non-small cell lung cancer
159. A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma
160. The cost of palliative care for hepatocellular carcinoma in Hong Kong.
161. Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma
162. Decreased tissue beta-galactoside alpha-2,6-sialyltransferase activity in hepatocellular carcinoma – a possible cause for the formation of tumour-specific alpha-fetoprotein isoforms.
163. 507O EXCLAIM-2: Phase III trial of first-line (1L) mobocertinib versus platinum-based chemotherapy in patients (pts) with epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)+ locally advanced/metastatic NSCLC.
164. 565P Genome-guided targeted therapy combination improves survival in patients with advanced EGFR mutation positive NSCLC failing osimertinib.
165. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.
166. 474 Hepatitis B virus genomic markers for hepatocellular carcinoma on full-genome sequencing of 332 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.